DEVELOPMENT SAFETY UPDATE REPORT Sequential FDG PET and Plasma/Tissue miRNA as a Biomarkers of Preoperative Treatment Strategy in Locally Advanced Oesophago Gastric Cancer Phase II Period covered: 15.10.2020 – 14.10.2021

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F21%3A00123089" target="_blank" >RIV/00216224:14110/21:00123089 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

DEVELOPMENT SAFETY UPDATE REPORT Sequential FDG PET and Plasma/Tissue miRNA as a Biomarkers of Preoperative Treatment Strategy in Locally Advanced Oesophago Gastric Cancer Phase II Period covered: 15.10.2020 – 14.10.2021

Original language description

Clinical Trial GastroPET EudraCT: 2017-001264-38 The clinical trial interim report describes the course and current status of the clinical trial (KH) in a defined period. It includes information on document updates, changes in KH centers and examiners, an overview of previously included/completed subjects of evaluation, and detected protocol violations. It also contains information on investigational medicine (reporting serious adverse events, suspicions of serious (unexpected) adverse events, or new findings in relation to safety and efficacy), new measures taken, and audits performed.

Czech name

—

Czech description

—

Type

V_souhrn - Summary research report

CEP classification

—

OECD FORD branch

30230 - Other clinical medicine subjects

Project

<a href="/en/project/LM2018128" target="_blank" >LM2018128: Czech National Node of the European Clinical Research Infrastructure Network</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2021

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Number of pages

3

Place of publication

Brno

Publisher/client name

MOÚ

Version

—